1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Emerging Infections Sentinel Networks is sponsored by Department of Health And Human Services. In its 1994 monograph, Addressing Emerging Infectious Disease Threats – A Prevention Strategy for the United States, the Centers for Disease Control and Prevention (CDC) called for the establishment of provider-based Emerging Infections Sentinel Networks (EISNs) to monitor and evaluate conditions that are not covered by health department surveillance and that are likely to be seen by specific kinds of health providers.
Objectives for the provider-based sentinel networks include the following:
- To support linked groups of participating individuals or organizations in monitoring a variety of infectious disease problems and enhancing communication and collaboration among network members and the public health community;
- To serve as readily accessible mechanisms to address urgent public health infectious disease problems rapidly; and
- To improve understanding of specific public health issues, including, but not limited to, international travel, and enhance preparedness to meet new infectious disease threats among domestic and globally mobile populations.
Additional objectives for the "research" EISN include:
- To focus studies on the most important issues to be addressed by participating hospital EDs and CDC; and
- To estimate the community burden of diseases. This listing is currently active. Program number: 93.860. Last updated on 2026-01-12.
Get alerted about grants like this
Get emailed when new opportunities from “Department of Health And Human Services” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Eligibility for this program is open, however, only institutions/organizations that meet and can demonstrate the necessary qualifications described in the published NOFOs for this program should apply. Additional eligibility information is also described below: There are both research and non-research funding opportunities under this program. For the research opportunity, only organizations currently operating a nationwide provider-based sentinel network that link academically affiliated hospital emergency departments in monitoring a variety of infectious disease problems are eligible. For the non-research opportunity, only organizations currently operating provider-based sentinel networks that link groups of participating individuals or organizations organized around either infectious disease clinicians or travel medicine in monitoring a variety of infectious disease problems are eligible. Applicants should refer to the published NOFOs for more information regarding applicant eligibility. Eligible applicant types include: Unrestricted by Entity Type. Confirm the full requirements in the official notice before applying.
The current listing shows recent federal obligations suggest $555,000 (2026). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Yes — Emerging Infections Sentinel Networks is offered by Department of Health And Human Services and this listing comes from SAM.gov, an official U.S. federal source. Federal applications generally require registrations (for example SAM.gov or an agency submission portal), so allow extra lead time.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress for early detection and assessment of individuals at risk and for early diagnosis, prognosis and follow-up of type 1 diabetes (T1D). Funding Opportunity Number: RFA-DK-15-024. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL. Award Amount: $2M total program funding.
This initiative will stimulate and support innovative research by small business concerns that may lead to the development of novel technologies for the early diagnosis, monitoring and treatment of micro and macro vascular complications of diabetes which are associated with significant morbidity and mortality of the disease and high costs to the health care system. Funding Opportunity Number: PA-14-058. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL.
The STOMP program funds measurement tools and removal therapies for microplastics in human tissue. Proposals due June 22. Eligibility, phases, and strategy.
Read articleThe Elevance Health Foundation's FY2026 Maternal/Infant Health cycle offers grants around $1 million (1–3 years, 15% indirects) to reduce pre-term birth and severe maternal morbidity. But eligibility hinges on a specific 501(c)(3) subsection test, funding concentrates in 10 states plus national scalable programs, and a corporate payer-funder judges you on measurable outcomes, not need. Here is how to read this RFP and compete before the July 31 deadline.
Read articleElevance Health Foundation's maternal/infant health RFP closes July 31, 2026, part of a five-year, $150 million commitment. Last cycle it awarded 29 grants totaling $6.5M across the pregnancy continuum. Here is what the funder actually rewards — measurable disparity reduction, a 15% indirect-cost cap, and scalable models — plus how nonprofits in the 10 priority states should frame a competitive proposal.
Read article